5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.19▲ | 7.17▲ | 7.17▲ | 7.55▼ | 7.44▼ |
MA10 | 7.18▲ | 7.15▲ | 7.17▲ | 7.43▼ | 7.58▼ |
MA20 | 7.16▲ | 7.16▲ | 7.43▼ | 7.47▼ | 8.00▼ |
MA50 | 7.16▲ | 7.54▼ | 7.50▼ | 7.68▼ | 7.65▼ |
MA100 | 7.24▼ | 7.45▼ | 7.39▼ | 8.04▼ | 7.51▼ |
MA200 | 7.51▼ | 7.42▼ | 7.42▼ | 7.97▼ | 7.37▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.010▲ | 0.025▲ | -0.022▼ | 0.016▲ | -0.120▼ |
RSI | 56.246▲ | 46.203▼ | 43.008▼ | 44.601▼ | 45.377▼ |
STOCH | 73.321 | 58.388 | 38.161 | 58.345 | 29.314 |
WILL %R | -5.882▲ | -5.556▲ | -78.161▼ | -75.410▼ | -79.560▼ |
CCI | 100.325▲ | 182.609▲ | -2.866 | -67.228 | -60.883 |
▼ BREAK | $AGLE Price Breaks 20 Days Low | Set Alert |
Monday, March 01, 2021 01:29 AM
State of Wisconsin Investment Board cut its stake in shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) by 11.1% during the 4th quarter, according to the company in its most recent disclosure with ...
|
Wednesday, February 24, 2021 08:30 AM
AUSTIN, Texas, Feb. 24, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as ...
|
Sunday, February 21, 2021 09:45 PM
Aeglea BioTherapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/03/21 | 7.25 | 7.32 | 7.07 | 7.25 | 172,910 |
04/03/21 | 7.91 | 7.91 | 7.03 | 7.15 | 243,906 |
03/03/21 | 7.75 | 8.17 | 7.7301 | 7.82 | 339,062 |
02/03/21 | 7.78 | 7.8474 | 7.69 | 7.75 | 146,166 |
01/03/21 | 7.45 | 7.85 | 7.45 | 7.79 | 145,144 |
26/02/21 | 7.46 | 7.55 | 7.05 | 7.45 | 182,623 |
25/02/21 | 7.28 | 7.55 | 7.11 | 7.39 | 270,273 |
24/02/21 | 7.19 | 7.35 | 7.03 | 7.27 | 97,103 |
23/02/21 | 7.25 | 7.26 | 6.95 | 7.11 | 204,428 |
22/02/21 | 7.24 | 7.50 | 7.10 | 7.36 | 150,551 |
|
|
||||
|
|
||||
|
|